Advertisement
Fragmin (dalteparin sodium) injection has been granted the first approval for subcutaneous use in preventing recurrence of symptomatic venous thromboembolism in children aged 1 month or older

First Anticoagulant Approved for Preventing VTE Recurrence in Children

0
Boxed warning lists risk for epidural, spinal hematomas with neuraxial anesthesia, spinal puncture
Prices paid to hospitals for privately insured patients in 2017 averaged 241 percent of what Medicare would have paid

Private Insurers Pay 241 Percent of What Medicare Would Pay

0
RAND researchers recommend private insurers move toward fixed-price arrangements
More than 50

Many Lives Could Be Saved if All Hospitals Had Grade A Rating

0
Patients at D, F hospitals have 91.8 percent increased risk for avoidable death compared with A hospitals
Dabigatran is not superior to aspirin for preventing recurrent stroke in patients with recent history of embolic stroke of undetermined source

Dabigatran Does Not Beat Aspirin for Preventing Recurrent Stroke

0
Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source
Guidelines have been updated for screening and treatment for tuberculosis infection among health care personnel

Recs Updated for TB Screening, Treatment in Health Care Workers

0
Guidelines include preplacement TB risk assessment, postexposure symptom evaluation and testing
Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma in combination with axitinib

Avelumab + Axitinib Approved for Treatment of Renal Cell Carcinoma

0
Treatment combination demonstrated longer progression-free survival versus sunitinib in randomized trial
Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia

0
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival
For opioid-naive patients treated for a surgical musculoskeletal injury

Opioid Quantity Prescribed After Musculoskeletal Injury Tied to Prolonged Use

0
Opioid type not predictive of prolonged use for patients with musculoskeletal injury undergoing surgery
Thyroid hormones are not recommended for adults with subclinical hypothyroidism

Thyroid Hormones Not Endorsed for Subclinical Hypothyroidism

0
Almost all adults with SCH would not benefit from treatment with thyroid hormones
Receipt of tramadol alone after surgery is associated with an increased risk for prolonged opioid use

Risk for Prolonged Opioid Use Up in Patients Receiving Tramadol

0
Those receiving tramadol postop have similar, higher risks as those receiving other short-acting opioids